Harrow (HROW) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Harrow (HROW) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn | -84.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -128.52% |
| Mar 31, 2026 | -95.78% |
| Dec 31, 2025 | 61.35% |
| Sep 30, 2025 | 1,410.65% |
| Jun 30, 2025 | -13.95% |
| Mar 31, 2025 | -29.93% |
| Dec 31, 2024 | 35.56% |
| Sep 30, 2024 | 26.83% |
| Jun 30, 2024 | -52.28% |
| Mar 31, 2024 | -30.55% |
| Dec 31, 2023 | -26.48% |
| Sep 30, 2023 | -50.43% |
| Jun 30, 2023 | 27.34% |
| Mar 31, 2023 | 30.59% |
| Dec 31, 2022 | -28.83% |
| Sep 30, 2022 | 91.91% |
| Jun 30, 2022 | 79.95% |
| Mar 31, 2022 | 144.63% |
| Dec 31, 2021 | 12.27% |
| Sep 30, 2021 | -1.10% |